VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia

NCT00505700 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: velcade
DRUG: Idarubicin
DRUG: Cytarabine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]